Zoetis Inc. — Director's Dealing 2020

Jan 8, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Zoetis Inc. (ZTS)
CIK: 0001555280
Period of Report: 2020-01-01

Reporting Person: Nayak Abhay U (Senior Vice President)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$		Common Stock (2033.8191)		Direct
Stock Option	$		Common Stock (1147.0)		Direct

Footnotes

F1: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F3: Not applicable.

F4: The RSUs vest as follows: 1,747.5549 RSUs will vest on July 31, 2021; and 286.2642 RSUs will vest on February 12, 2022.

F5: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F6: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7: Each option vests on the third anniversary of the date of grant.

F8: Each option expires on the tenth anniversary of the date of grant.

F9: 1,147 options granted February 12, 2019 at an exercise price of $87.51 per option.